SEC Form 4 · accession 0001209191-19-006583
HCA Healthcare, Inc. · HCA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
J William Morrow
Officer — SVP - Finance and Treasurer
Period of report
Jan 30, 2019
Accepted (ET)
Feb 1, 2019 · 6:04 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000860730
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Jan 30, 2019 | S | 3,224 | $137.1903 | D | 6,210 | D | |
| Common Stock | holding | — | — | — | 1,809 | I | By Trust (Spouse, Trustee) |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Appreciation RightF3 | $139.06 | Jan 30, 2019 | A | 8,000 | A | Jan 30, 2020 | Jan 30, 2029 | Common Stock | 8,000 | 8,000 | D |
Explanation of responses
- F1The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $137.11 to $137.35, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F2Includes 960.3464 shares acquired under the HCA Holdings, Inc. Employee Stock Purchase Plan.
- F3The stock appreciation rights vest in four equal annual installments beginning on January 30, 2020.